Hyponatremia and comparison of NT-pro-BNP concentrations in blood samples from jugular bulb and arterial sites after traumatic brain injury in adults: A pilot study

Neurocritical Care

Volumn 7, Issue 2, 2007, Pages 119-123

  Powner, David J ^a,b   Hergenroeder, Georgene W ^a   Awili, Mustafa ^c   Atik, Mustafa A ^c   Robertson, Claudia ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Brain; Brain injuries; Natriuretic hormone; Natriuretic peptide; Nervous system; Trauma

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPONATREMIA; MALE; PILOT STUDY; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; STATISTICAL SIGNIFICANCE; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; ARTERIES; BRAIN; BRAIN INJURIES; FEMALE; HUMANS; HYPONATREMIA; JUGULAR VEINS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PILOT PROJECTS; SODIUM;

EID: 36949011611     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-007-0079-8     Document Type: Article

References (36)

1. Cole CD, Gottfried ON, Liu JK, Couldwell WT. Hyponatremia in the neurosurgical patient: diagnosis and management. Neurosurg Focus 2004;16:1-10.
2. Rabinstein AA, Wijdicks EFM. Hyponatremia in critically ill neurological patients. Neurologist 2003;9:290-300.
3. Bhardwaj A. Neurological impact of vasopressin dysregulation and hyponatremia. Ann Neurol 2006;59:229-36.
4. Hasan D, Wijdicks EFM, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneursymal subarachnoid hemorrhage. Ann Neurol 1990;27:106-8.
5. Wehner F, Olsen H, Tinel H, Kinne-Saffran E, Kinne RKH. Cell volume regulation: osmolytes, osmolyte transport, and cell signal transduction. Rev Physiol Biochem Pharmacol 2003;148:1-80.
6. Jason P, Keang LT, Hoe LK. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med 2005;33:2094-103.
7. Witthaut R. Science review: naturiuretic peptides in critical illness. Crit Care 2004;8:342-9.
8. Marumo F, Masuda T, Ando K. Presence of the atrial natriuretic peptide in human cerebrospinal fluid. Biochem Biophys Res Commun 1987;143:813-8.
9. Antunes-Rodrigues J, de Castro M, Elias LLK, Valenca MM, McCann SM. Neuroendocrine control of body fluid metabolism. Physiol Rev 2004;84:169-208.
10. Sudo T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
11. Takahashi K, Totsune K, Sone M, Ohneda M, Murakami O, Itoi K, et al. Human brain natriuretic peptide-like immunoreactivity in human brain. Peptides 1992;13:121-3.
12. Wiedemann K, Jahn H, Kellner M. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. Exp Clin Endocrinol Diabetes 2000;108:5-13.
13. Togashi K, Kameya T, Ando K, Marumo F, Kawakami M. Brain natriuretic peptides in human plasma, spinal cord and cerebrospinal fluid. Clinica Chimica Acta 1991;201:193-200.
14. Kirchhoff C, Stegmaier J, Bogner V, et al. Intrathecal and systemic concentration of NT-proBNP in patients with severe traumatic brain injury. J Neurotrauma 2006;23:943-9.
15. McLean AS, Huang SJ, Nalos M, Tang B, Stewart DE. The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 2003;31:2611-8.
16. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Comparison of the Biomedica NT-proBNP Enzyme Immunoassay and the Roche NT-proBNP Chemiluminescence Immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. Clin Chem 2003;49:976-9.
17. Sviri GE, Soustiel JF, Zaaroor M. Alteration in brain natriuretic peptide(BNP) plasma concentration following severe traumatic brain injury. Acta Neurochir 2006;148:529-33.
18. Powner DJ, Boccalandro C, Alp MS, Vollmer DG. Endocrine failure after traumatic brain injury in adults. Neurocritic Care 2006;5:61-70.
19. Agha A, Thornton E, O'Kelly P, Tormey W, Phillips J, Thompson CJ. Posterior pituitary dysfunction after traumatic brain injury. J Clin Endocrinol Metab 2004;89:5987-92.
20. Baylis PH. The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol 2003;35:1495-99.
21. Cai JN, Wang GL, Yi J. Clinical analysis of the syndrome of inappropriate antidiuretic hormone secretion after brain injury. Chin J Traumatol 2003;6:179-81.
22. Singh S, Bohn D, Carlotti APCP, Cusimano M, Rutka JT, Halperin ML. Cerebral salt wasting: truths, fallacies, theories, and challenges. Crit Care Med 2002;30:2575-79.
23. Sviri GE, Shik V, Raz B, Soustiel JF. Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochir 2003;145:851-60.
24. Nagami M, Shiga J, Takatsu A, Endo N, Ishiyama I. Immunohistochemistry of atrial natriuretic peptide in brain infarction. Histochem J 2001;33:87-90.
25. Obi T, Takatsu M, Konishi T, Mizoguchi K, Nichimura Y. Secretion of natriuretic peptides caused by an epileptic attack. Acta Neurol Scand 2002;106:225-8.
26. Nakagawa K, Yamaguchi T, Seida M, Tanaka Y, Yoshino M. Plasma concentrations of atrial and brain natriuretic peptides in a case with hypertensive encephalopathy. Neurol Res 2002;24:627-30.
27. McGirt MJ, Blessing R, Nimjee SM, Friedman AH, Alexander MJ, Laskowitz DT, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 2004;54:1369-73.
28. Almog Y, Novack V, Megralishvili R, et al. Plasma level of N terminal pro-grain natriuretic peptide as a prognostic marker in critically ill patients. Anesth Analg 2006;102:1809-15.
29. Espiner EA, Leikis R, Ferch RD, et al. The neuron-cardioendocrine response to acute subarachnoid haemorrhage. Clin Endocrinol 2002;56:629-35.
30. Vuolteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease. Adv Clin Chem 2005;40:1-36.
31. Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock and acute heart failure. Crit Care Med 2006;34:2140-4.
32. 2 terminal probrain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 2005;33:1001-7.
33. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 2004;109:2872-7.
34. Tung PP, Olmsted E, Kopelnik A, et al. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke 2005;36:1567-9.
35. Palac RT, Sumner G, Laird R, O'Rourke DJ. Reversible myocardial dysfunction after traumatic brain injury: mechanisms and implications for heart transplantation. Prog Transplant 2003;13:42-6.
36. Wittebole X, Hantson P, Laterre PF, Galvez R, Duprez T, Dejonghe D, et al. Electrocardiographic changes after head trauma. J Electrocardiol 2005;38:77-81.